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Abstract.  The human asialoglycoprotein receptor is a 
heterooligomer of the two homologous subunits H1 
and H2.  As occurs for other oligomeric receptors,  not 
all of the newly made subunits are assembled in the 
RER into oligomers and some of each chain  is 
degraded.  We studied the degradation of the unassem- 
bled H2 subunit in fibroblasts that only express H2 
(45,000 mol wt) and degrade all of it.  After a  30 min 
lag,  H2 is degraded with a half-life of 30 min.  We 
identified a  35-kD intermediate in H2 degradation;  it 
is the COOH-terminal,  exoplasmic domain of H2.  Af- 
ter a 90-min chase, all remaining  intact H2 and the 
35-kD fragment were endoglycosidase H  sensitive, 
suggesting that the cleavage generating the 35-kD in- 
termediate occurs without translocation to the medial 
Golgi compartment.  Treatment of cells with leupeptin, 
chloroquine,  or NI-LCI did not affect H2 degradation. 
Monensin slowed but did not block degradation.  Incu- 
bation at  18-20°C slowed the degradation  dramatically 
and caused an increase in intracellular  H2, suggesting 
that a membrane tratficking event occurs before H2 is 
degraded.  Immunofluorescence microscopy of cells 
with or without an  18°C preincubation  showed a 
colocalization of H2 with the ER and not with the 
Golgi complex. We conclude that H2 is not degraded 
in lysosomes and never reaches the medial Golgi com- 
partment in an intact form, but rather degradation  is 
initiated  in a pre-Golgi compartment,  possibly part of 
the ER.  The 35-kD fragment of H2 may define an ini- 
tial proteolytic cleavage in the ER. 
M 
ANY cell surface receptors and  secreted proteins 
are composed of multiple  subunits.  The assembly 
of the individually  synthesized subunits  into com- 
plexes is not a perfectly efficient process; in many instances, 
a fraction of the subunits made is never assembled or routed 
to the cell surface (e.g., Dulis et al.,  1982; Merlie et al., 
1982;  Plant  and  Grieninger,  1986;  Corless et al.,  1987; 
Minami et al., 1987). The human hepatic asialoglycoprotein 
(ASGP) ~ receptor is an attractive  system in which to study 
this process. This receptor is composed of two strongly ho- 
mologous  subunits,  H1  and  H2.  Studies  using  chemical 
cross-linking  and  antibody-induced  degradation  showed 
that,  in the human hepatoma cell line HepG2, the receptor 
is a heterooligomer (Bischoff et al.,  1988).  The functional 
complex is at least a trimer,  containing  at least one H2 and 
two (or three) HI polypeptides. HI is synthesized as a 40-kD 
core-glycosylated precursor, oriented in the ER membrane 
with its NH2 terminus in the cytoplasm and its COOH ter- 
minus in the ER lumen.  During transit  through  the Golgi 
complex, the modification  of its two N-linked  oligosaccha- 
ride chains causes a size increase to ~46 kD. Similarly, H2 
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is synthesized as a 43-kD transmembrane protein with three 
high-mannose  oligosaccharide  chains and is then modified in 
the Golgi complex to the mature form of ~50 kD. In HepG2 
cells, about one third of newly made H1 and H2 never ac- 
quires complex oligosaccharides  and is degraded (Bischoff 
and Lodish,  1987). 
The necessity for both subunits for normal receptor func- 
tion was demonstrated  by the expression of cDNA clones in 
hepatoma  or fibroblast cells. For both the rat (McPhaul  and 
Berg,  1986)  and  human  (Shia  and  Lodish,  1989) ASGP 
receptors,  expression of both subunits  is needed for high- 
affinity binding of proteins with triantennary  sugars.  More- 
over, the two subunits of the human receptor have different 
intracellular  fates when expressed separately. When H1 is ex- 
pressed alone  in  3T3  fibroblasts  (which normally do not 
make the receptor), most of the HI forms oligomers contain- 
ing at least three subunits, is processed, and is targeted to the 
cell surface. However, it cannot bind a normal ligand, asialo- 
orosomucoid (Shia and Lodish, 1989). Cells expressing the 
homologous rat protein,  RHL-1, can bind and endocytose a 
protein containing  many chemically attached galactose resi- 
dues but not asialoorosmucoid (Braiterman  et al., 1989). In 
contrast, H2 expressed alone in 3T3 cells, although  it is in- 
serted  normally into the RER and receives high-mannose 
oligosaccharides, fails to be processed to its mature form, and 
disappears from the cells (Shia and Lodish, 1989). The cell 
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study the degradation of unassembled receptor subunits- 
most likely this is the same mechanism operating in fibro- 
blasts that express both subunits but degrade part of each. 
We show here that at least an initial step of H2 degradation 
occurs in a pre-Golgi compartment that may be part of the 
ER. Lysosomotropic agents do not affect the degradation of 
H2 nor cause accumulation of any detectable intermediates. 
Thus, the characteristics of degradation are similar to those 
described for the c~ and/3 subunits of the T cell receptor in 
transfected fibroblasts (Lippincott-Schwartz et al., 1988) and 
for the CD3-5 subunit of the T cell receptor in a T cell hy- 
bridoma lacking the/~ chain (Chen et al.,  1988). This indi- 
cates that pre-Golgi,  nonlysosomal degradation may be a 
general mechanism used by cells to handle improperly folded 
or unassembled membrane proteins.  In addition,  we have 
identified a fragment of H2, consisting of only the exoplas- 
mic domain, that may define an initial proteolytic cleavage 
in the ER. 
Materials and Methods 
Materials 
Materials were obtained from the following sources: L-[35S]cysteine (spe- 
cific radioactivity of >800 Ci/mmol) was from New England Nuclear (Bos- 
ton, MA), Amersham Corp. (Arlington Heights, IL), or ICN Radiochemi- 
cals (Irvine, CA); t4C-methylated protein standards were from Amersham 
Corp.;  protein  A-agarose  was  from  Bethesda  Research  Laboratories 
(Gaithersburg,  MD);  leupeptin was from Chemicon (El  Segundo, CA); 
chloroquine and  monensin were from Sigma Chemical Co.  (St.  Louis, 
MO); endoglycosidase (endo) H was from Genzyme Corp. (Boston, MA); 
endo D was from Boehringer Mannheim Biochemicals (Indianapolis, IN); 
bicinchoninic acid protein assay reagent was from Pierce Chemical Co. 
(Rockford, IL); calf serum and DME were from Gibeo Laboratories (Grand 
Island, NY); tissue culture dishes were from Costar (Cambridge, MA) and 
Falcon Labware (Oxnard, CA). 
Antibodies 
We used several antibodies specific for the ASGP receptor subunits: an an- 
tiserum specific for the H2 cytoplasmic domain, raised against a peptide 
corresponding to amino acids 24-33 of H2; an antiserum specific for the 
H2  COOH  terminus,  raised against a  peptide corresponding to the  12 
COOH-terminal residues; and an antiserum specific for HI, raised against 
a peptide corresponding to the 15-COOH-terminal amino acids (Bischoff 
et  al.,  1988).  These were kindly provided by  Drs.  Joyce Bischoff and 
Michael Shia (Whitehead Institute for Biomedical Research, Cambridge, 
MA). The other antisera used were anti-RER and anti-Golgi complex, pre- 
pared against whole fractions of purified RER or Golgi membranes (Lou- 
yard et al.,  1982),  kindly provided by Dr. Daniel Louvard of the Pasteur 
Institute (Paris, France). 
Cell Culture 
The NIH 3T3 retrovirus-infected  cell lines 1-7-1 (expressing HI and H2) and 
2-18 (expressing H2) (Shia and Lodish,  1989) were grown in DME plus 
10%  calf serum under an atmosphere of 5%  CO2.  The cell monolayers 
were trypsinized and split I:10 to 1:60 into 60-ram tissue culture dishes at 
least 2 d before use. 
Metabolic Labeling 
Subconfluent to just confluent (80-100%) monolayers were rinsed once in 
DME devoid of cysteine but supplemented with 10% dialyzed calf serum 
(cysteine-free DME), preincubated for 30 rain in 1 ml cysteine-free DME, 
then incubated with [3sS]cysteine (170-250 #Ci/ml) in 0.7 ml cysteine-free 
DME for various lengths of time at 37°C in a 5% COz atmosphere. To ter- 
minate the  pulse,  we  removed the  radioactive  medium and  rinsed the 
monolayers two to three times with DME (containing cysteine) at 370C and 
then returned them to the incubator with 3-5 ml DME for different chase 
periods. For the experiments with ieupeptin, the drug was present in the 
medium during the preincubation, pulse, washes, and chase. For the experi- 
ments in which temperature was varied or in which monensin, chioroquine, 
or NI-L;CI was used, the sodium bicarbonate in the medium was substituted 
with 20 mM Hepes and the pH was adjusted to 7.2. In this case, incubations 
were done outside of the CO2 incubator. After the given chase period, we 
placed the dishes on ice and rinsed them twice in PBS and then lysed the 
monolayers in 600 pl of 1% Triton X-100, 0.5% sodium deoxycholate, 10 
mM EDTA, 2 mM PMSF in PBS (lysis buffer). (In some experiments, the 
additional protease inhibitors L-l-p-tosylamino-2-phenylethyl  chloromethyl 
ketone and N-p-tosyl-L-lysine chloromethyl ketone [100 ~g/ml] were in- 
cluded in the lysis buffer,  with no difference in the results.) Alternatively, 
we generated a postnuclear supornatatu as described (Bischoff and Lodish, 
1987),  but using 50 strokes with the homogenizer (Dounce; Kontes Glass 
Co., Vineland, NJ); the postuuclear supernatant was adjusted to 1×  PBS, 
1% Triton X-100, 0.5%  sodium deoxycholate, 2 mM PMSE After either 
sample preparation method, the suspension was transferred to a microfuge 
tube, mixed vigorously, incubated on ice for at least 1 h, remixed, and cen- 
trifuged for 15 min at 15,000 g at 40C to remove debris. We used the bicin- 
cboninic acid protein assay reagent (Pierce Chemical Co.), with BSA as a 
standard, to determine the protein concentration in the supernatant ("cell ex- 
tract"). 
Immunoadsorption and Electrophoresis 
All  steps were carried out  at  0-4°C  unless otherwise noted.  We  used 
amounts of cell extract or postnuclear supernatant extract representing a 
given amount of protein, typically 200/~g, in each experiment, adjusting 
the total volume of the immunoadsorption with lysis buffer.  We incubated 
samples with normal rabbit serum (used at a 1:200 dilution) for at least 1 h 
on ice or 30 rain at room temperature and then added 12 #l of a 25% slurry 
of protein A-agarose in PBS, 0.02%  sodium azide//~l of serum. After incu- 
bation with rotation for at least another 30 min, we centrifuged samples at 
15,000 g for 30 s and transferred the supernatants to tubes containing the 
appropriate antiserum. Antisera were used at a  1:70 dilution, and the incu- 
bation was continued overnight, conditions we found to be sufficient to leave 
no immunoadsorbable material in the supernatant. Samples were then in- 
cubated  with  protein A-agarose as  above.  The  protein A-agarose  was 
washed, and the antigen-antibody complexes were eluted, denatured, and 
subjected to SDS-10% PAGE, fluorography, and densitometry as described 
(Bischoff and Lodish,  1987). 
endo H Digestion 
After immunoadsorption, antigen-antibody complexes were eluted from 
protein A-agarose by incubation at  100°C  for 5 min in 20/~1 0.5%  SDS, 
0.1  M  sodium citrate, pH 6,  diluted with 80/d  1.25 mM EDTA,  1 mM 
PMSE 0.1 M sodium citrate, pH 6, and then centrifuged at 15,000 g to pellet 
the protein A-agarose. The supernatants were divided into halves and in- 
cubated overnight either with no addition or with 30 ng of endo H per 45-/~1 
sample. 23 p.1 of 3 x  concentrated SDS-PAGE sample buffer was added to 
each sample, and samples were heated to 100°C and processed by SDS-10% 
PAGE as above. 
Immunofluorescence Microscopy 
Cells grown on coverslips were fixed and permeabilized by sequential incu- 
bation with methanol and acetone for 5 min each at -20°C. They were then 
rinsed with PBS containing 2% BSA (PBS-BSA) three times and subjected 
to the following sequential incubations: (a) 30 rain with normal goat IgG; 
(b) 60 min with rabbit anti-H2 COOH terminus IgG affinity purified on a 
column of protein A-sepharose; (c) three rinses with PBS-BSA; (d) 30 rain 
with 5/~g/ml TRITC-conjugated goat anti-rabbit IgG; (e) two rinses with 
PBS-BSA; (f) 60 min with 100 t~g/ml unlabeled goat anti-rabbit IgG; (g) 
three rinses with PBS-BSA; (h) 60 min with rabbit anti-RER or rabbit 
anti-Goigi serum; (i) three rinses with PBS-BSA; (j) 30 min with 5/~g/ml 
FITC-goat anti-rabbit IgG; and (k) three rinses with PBS. 
Cells  were  viewed on a  fluorescence microscope (Carl  Zeiss,  Inc., 
Thornwood, NY) with FITC and TRITC filters and photographed at identi- 
cal exposure times between samples to be able to compare signal intensities. 
Controls, in which any of the primary antibodies were omitted or replaced 
by preimmune IgG,  showed no detectable signal with the corresponding 
filter. 
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with [35S]cysteine  for 30 min then washed and incubated with non- 
radioactive medium for 0, 1, or 2 h. The experiment was done in 
duplicate. Detergent extracts of the cells (C; lanes 1-3, 5, 7, and 9) 
and medium (M; lanes 4, 6, 8, and 10) were immunoprecipitated 
with a mixture of antisera directed against the NH2 and COOH 
termini of H2. The immunoadsorbed material was electrophoresed 
using SDS-PAGE, fluorographed, and subjected to autoradiogra- 
phy. The open and closed arrowheads at the left indicate the intact 
H2 polypeptide and a 35-kD putative degradation product, respec- 
tively. The protein standards at the right are in kilodaltons. 
Results 
H2 Is Degraded after a Small Decrease in Size 
mRNAs encoding two variants of H2, H2a and H2b, are tran- 
scribed in  HepG2 cells (Spiess and Lodish,  1985).  Com- 
pared with H2b, H2a contains a five-amino acid insert after 
amino acid number 81, which is located in the exoplasmic 
domain just  beyond the membrane-spanning  region.  One 
difference  between the variants is that, when expressed alone 
in 3T3 fibroblasts, a portion of H2b reaches the cell surface 
(Lederkremer, G., and H. E  Lodish, unpublished results), 
while none of H2a does (Shia and Lodish,  1989).  In 2-18 
cells, a line of retrovirus-infected 3T3 fibroblasts expressing 
only H2a, the H2 polypeptide is synthesized as the usual 43- 
kD core-glycosylated precursor but then disappears rapidly 
and completely from the cells (Shia and l.axtish,  1989). We 
used 2-18 cells to study H2 degradation in the complete ab- 
sence of surface expression. 
We wanted first to establish whether the disappearance of 
radioactively labeled H2 after a pulse labeling of 2-18 cells 
was due to complete intracellular proteolysis or to partial 
cleavage of  the polypeptide followed by fragment release into 
the medium; the latter occurs to some viral integral mem- 
brane glycoproteins such as the vesicular stomatitis virus G 
protein (Chen and Huang,  1986). To test this possibility, we 
pulse labeled 2-18 cells, chased for 1 or 2 h, and immunoad- 
sorbed detergent extracts of the cells and the medium with 
a mixture of antipeptide antisera directed against epitopes of 
the  cytoplasmic  (NH2-terminal)  and  exoplasmic  (COOH- 
terminal) domains of H2 (Bischoff  and Lodish, 1987; Bischoff 
et al., 1988) (Fig.  1). Because we detected no immunoreac- 
tive material in the medium, we conclude that H2 is indeed 
intracellularly degraded and not simply cleaved once and 
secreted. 
The  major  H2  polypeptide  (Fig.  1,  open  arrowhead) 
migrated slightly faster after 1 h of chase than did the pulse- 
labeled species. This ,~l-l.3-kD decrease in size is due to 
modification of the oligosaccharide, not of the peptide back- 
bone, because after endo H digestion to remove the oligosac- 
charides the pulse-labeled and chased samples had the same 
mobility (data not shown). A faint band of ,x, 35 kD (solid 
arrowhead) was seen in the chase samples; as noted below, 
we suspect this is an intermediate in H2 degradation. This 
polypeptide was never detected in 3T3 cells infected with 
vector alone (not shown). 
Time Course of  H2 Degradation 
The time course of degradation of newly synthesized H2 is 
shown in Fig.  2.  In  this  and similar experiments, we ob- 
served that H2 was relatively stable for 30-60 rain and then 
degraded rapidly with a  half-life of 30 min,  as previously 
reported by Shia and Lodish (1989). The 35-kD polypeptide 
was detected initially at 15 min of  chase and was present dur- 
ing the time in which H2 was disappearing most rapidly; it 
was undetectable by 3 h of chase. The time course of the ap- 
pearance and disappearance of the 35-kD species is consis- 
tent with a role as an intermediate in the degradation of H2. 
The 35-kD Polypeptide Contains the COOH Terminus 
of  H2 and Is Formed in the ER 
To characterize further this putative degradation intermedi- 
ate, we tested the reactivity of the 35-kD polypeptide with 
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Figure 2. The time course of H2 degradation. 2-18 cells were la- 
beled with [asS]cysteine  for 10 min and then washed and incubated 
with nonradioactive medium for the times shown. Solubilized pro- 
teins were subjected to immunoabsorption with anti-COOH termi- 
nus antiserum. The immunoadsorbed material was processed as in 
Fig.  1. The intensities of the radioactive species were quantitated 
by densitometry and normalized to the molar amount of H2 present 
at the beginning of the chase, taking into account that the 35-kD 
polypeptide contains 8 of the 11 cysteines present in intact H2 (cal- 
culated from data in Fig. 3). 
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endo H sensitivity of H2 and the 
35-kD fragment.  2-18 cells were 
pulse-labeled  with  [35S]cysteine 
for 15 min followed by a 90-rain 
chase  period,  and a postnuclear 
supernatant  was prepared  as de- 
scribed in Materials and Methods. 
It was immunoadsorbed with an- 
tisera  directed  against either  the 
NH2  terminus  (lane  1)  or  the 
COOH terminus (lanes 2 and 3) 
of H2. Aliquots of  the sample im- 
munoprecipitated  with  the  anti- 
COOH-terminal  antiserum  were 
incubated  overnight  with  either 
no addition (lane 2) or with endo 
H  (lane  3).  Samples  were  ana- 
lyzed by SDS-PAGE  and processed 
as usual. The open and closed ar- 
rowheads at the left point to intact H2 and the 35-kD fragment, re- 
spectively, in the untreated sample immunoadsorbed with the COOH 
terminus antiserum (lane 2); the arrowheads at right indicate their 
migration after endo H treatment (lane 3). The hatch marks at left 
indicate the migration of the 46- and 30-kD protein standards. 
antisera specific for different domains of H2  (Fig.  3).  An 
antiserum specific for the NH2 terminus of H2 immunoad- 
sorbed only undegraded H2 (lane 1, open arrowhead), where- 
as an antiserum specific for the COOH terminus of H2 rec- 
ognized both  intact  H2  and  the  35-kD  species.  Thus,  we 
expect the 35-kD polypeptide to contain the exoplasmic do- 
main of H2, including the three oligosaccharide chains, endo 
H treatment supports this notion (Fig. 3, lane 3). All the in- 
tact H2 remaining after a 90-min pulse was endo H sensitive; 
endo H reduced its size by 7-8 kD. Likewise, endo H diges- 
tion  completely shifted the  smaller band from 35  to  ~27 
kD, also a change of •8  kD, in agreement with the presence 
of three oligosaccharide chains. In addition,  neither the in- 
tact H2 nor the 35-kD fragment was sensitive to endo D (data 
not shown); this enzyme hydrolyses high-mannose type oligo- 
saccharides that  have an unsubstituted  c~-mannose residue 
that is in an ~1,3 linkage to the trisaccharide core. This struc- 
ture is typically the product of Golgi ~-mannosidase I, the 
first enzyme to act on glycoproteins that enter the cis-Golgi 
compartment. The endo H  sensitivity of the two H2 species 
is important for two reasons:  it indicates that H2 probably 
does not enter the Golgi complex before being degraded and 
that the proteolytic event generating the 35-kD polypeptide 
also takes place in a  pre-Golgi compartment. 
Because the antiserum that recognized the 35-kD species 
was raised against the 12 amino acids at the COOH terminus 
(exoplasmic domain) of H2, we can use the estimated sizes 
of the proteins in Fig. 3 to determine the site of cleavage that 
would generate the 35-kD product from H2. Using the esti- 
mated sizes of either the glycosylated or deglycosylated pro- 
teins, the predicted cleavage would be at amino acids 72-84. 
H2  spans the  membrane between  amino  acids  59  and  78 
(Spiess and Lodish,  1985), so the cleavage is near the junc- 
tion  between  the  membrane-spanning and  exoplasmic do- 
mains. Preliminary fractionation data suggest that the 35-kD 
polypeptide is not tightly associated with membranes (our 
unpublished observation), consistent with this localization of 
cleavage.  We  tried  to  find  the  remaining  portion  of H2, 
predicted to be "~8-10 kD, using a gel system that can resolve 
proteins as small as 1 kD but we were unable to detect any 
smaller band immunoreactive with the anti-NH2 terminus 
antiserum (data not shown).  Either the NH2-terminal frag- 
ment is degraded more rapidly than the 35-kD intermediate 
or, after the initial cleavage, it loses the epitope recognized 
by the anti-NH2 terminus antiserum. 
Interfering with Lysosomal Activity Does Not Affect 
H2 Degradation 
The lag in H2 degradation suggested that H2 travels from the 
RER to its degradation  site and that this transfer requires 
time. One candidate for the site of degradation is the lyso- 
some. To find out if H2 is degraded in lysosomes in these 
cells, we tested the effects on H2 degradation of several com- 
pounds known to interfere with lysosomal function. Incuba- 
tion of cel|s with high concentrations ofthiol protease inhibi- 
tors  inhibits  degradation  of proteins  that  are  degraded  in 
lysosomes (Ascoli, 1979; Harford et al.,  1983; Schwartz et 
al.,  1986;  Lippincott-Schwartz et al.,  1988);  this effect is 
presumed to be due to fluid-phase endocytosis of the inhibi- 
tors  followed by delivery to  the  lysosomes. We incubated 
cells with the protease inhibitor leupeptin (400 t~g/ml) for 30 
min  before  pulsing  them  with  [3sS]cysteine  and  included 
leupeptin in the pulse, wash, and chase media (Fig. 4). The 
Figure 4.  Effect of leupeptin  incubation on H2 degradation.  2-18 
cells were incubated with or without 400 t~g leupeptin/ml  for the 
30-min period of cysteine deprivation,  the 20-min pulse, and the 
2- or 4-h chase period,  as indicated. Cell extracts were made and 
processed as usual but with the inclusion of 2.5 ttg leupeptin/ml ly- 
sis buffer. Anti-COOH terminus  serum was used for immunoad- 
sorption.  The open and  closed  arrowheads  at  left  indicate  the 
migration of H2 and the 35-kD fragment, respectively. The arrow- 
heads  at  right  indicate  the  migration  of  protein  standards  in 
kilodaltons. 
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NH4C! on H2 degradation. 2-18 cells were pulse 
labeled with [35S]cysteine  for 20 min then washed 
and chased for 0, 2, 4, and 6 h in medium with no 
addition or containing monensin (100/~M), chlo- 
roquine (800 t~M), or NI-I4CI (20 mM) as indi- 
cated. Solubilized proteins were immunoadsorbed 
with anti-COOH terminus serum and processed as 
usual. The arrowheads at right indicate the migra- 
tion of protein standards, given in kilodaltons. In- 
tact H2 and the 35-kD fragment are indicated on 
the left by open and closed arrowheads, respec- 
tively. 
faster migrating polypeptides seen in the pulse-labeled sam- 
ples correspond to different numbers of N-linked oligosac- 
charides on H2 and on the proteolytic fragment because endo 
H  digestion reduced each pair to a  single band  (data not 
shown). 
If  the lysosomes were the site of H2 degradation, we would 
expect that degradation would be slowed by treatment with 
leupeptin; however, it was unaffected, as H2 decayed with 
approximately the same kinetics with and without leupeptin. 
This experiment must be considered in the light of results by 
Schwartz et al. (1986): although a 1-h preincubation with 500 
/~g  leupeptin/ml  inhibited  the degradation  of internalized 
~zsI'-asialoorosomucoid  *80%,  the  protease  inhibitor had 
no effect on the antibody-induced degradation of the ASGP 
receptor. This assay measures the degradation pathway taken 
by cell surface receptors after they have been induced to in- 
ternalize after exposure to anti-receptor antibodies.  From 
this and other results, including evidence that the weak base 
primaquine could inhibit degradation of the receptor, Schwartz 
et  al.  concluded that  these  internalized  receptors are  not 
degraded in the lysosomes but rather in an endosomal com- 
partment. 
To determine if H2 were targeted directly to such a degra- 
dative endosomal compartment in 2-18 cells, we tested the 
effects of compounds that interfere with endosome and lyso- 
some function, at concentrations greater than the concentra- 
tions that are maximally effective at neutralizing endosomes 
in 3T3 fibroblasts (Maxfield, 1982). Neither chloroquine nor 
NI-LCI,  weak bases  that are thought to inhibit  lysosomal 
and endosomal enzyme activity by raising the intralumenal 
pH, inhibited the breakdown of  H2 nor did they affect the ap- 
pearance or disappearance of the 35-kD fragment (Fig. 5). 
Monensin, a proton ionophore with multiple effects on cells 
including  the neutralization of acidic compartments (Tar- 
takoff, 1982), had very little effect on H2 degradation even 
at a concentration of 100 #M, an order of magnitude higher 
than that used by Lippincott-Schwartz et al. (7 #M), which 
had no effect on degradation of T cell receptor subunits. 
In a more detailed study of  the time course of degradation, 
monensin slowed the decay of H2 by ,~30-60 min relative 
to untreated cells, and H2 became almost undetectable be- 
tween 4  and 6  h  of chase (see Fig.  5).  Monensin also in- 
creased the accumulation of the 35-kD fragment (Fig.  5). 
Monensin at 100 #M concentration interferes not only with 
lysosomes; in 1-7 cells, which are 3T3 fibroblasts that synthe- 
si~ HI and express it at the cell surface (Shia and Lodish, 
1989), 100 #M monensin blocked conversion of H1 and H2 
oligosaccharides to the complex form (data not shown), sug- 
gesting that Golgi function or transport from the ER to the 
Golgi complex was affected, consistent with effects seen in 
other systems (Tartakoff,  1983).  Taken together, the phar- 
macological data suggests that H2 in 2-18 cells is not de- 
graded in lysosomes or endosomes. 
H2 Degrades  Slowly at 18-20°C 
Incubation of cells at •20°C  slows some processes that de- 
pend on lipid bilayer fluidity, such as membrane fission and 
fusion (Dunn et al., 1980; Marsh et al., 1983; Saraste et al., 
1986).  Lippincott-Schwartz et al.  found that incubation at 
18°C blocks degradation of T cell receptor ot and/3 chains. 
To determine whether H2 degradation shows a  similar be- 
havior, we incubated 2-18 and 1-7-1 cells at 18-20°C for both 
a pulse and chase period. The 1-7-1 cells were included as a 
measure of how the low temperature was affecting the move- 
ment of H2 from the RER to the Golgi complex, as moni- 
tored by the modification of H2 oligosaccharides to the com- 
plex form. Some H2 was also degraded in the 1-7-I cells, but 
the data are presented as a percentage of mature H2 com- 
pared with the total amount of H2 present at each time point; 
this may overestimate slightly the rate of maturation of H2. 
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Figure 6.  Slowing of H2 degradation or processing at 18-20°C. 
2-18 cells and 1-%1 cells were pulse labeled at 18-20°C with [35S]- 
cysteine for 20 min and then washed and incubated at 18-20°C for 
3, 8, or 18 h.  Solubilized H2 proteins were immunoprecipitated 
with anti-NH2 terminus antiserum, processed as usual, and then 
quantitated by densitometry. The data plotted for the 2-18 cells 
(open squares) are the percentage of H2 remaining at each time 
point compared with the pulse sample. The data for 1-7-1 cells (solid 
squares) are the amount of H2 converted to its high molecular 
weight form with complex sugars compared with the total amount 
of H2 present at each time point. 
Fig. 6, open squares,  shows that, in 2-18 cells, H2 decay was 
greatly slowed relative to that at 37°C (compare with Fig. 2), 
a half-life (after the lag period) of 11 h, relative to 30 min 
at 37°C. This rate was comparable with the ,~18-h half-time 
of rate of H2 maturation in 1-7-1 cells (Fig. 6, solid squares), 
consistent with the low temperature affecting movement of 
protein from one vesicular compartment to another. 
In 2-18 Cells H2 Is Detected in the ER and Not the 
Golgi Complex 
To see if we could identify a particular cellular compartment 
containing H2 in 2-18 cells, we used immunofluorescence to 
label simultaneously the ER and H2 (Fig. 7, A and B) or the 
Golgi complex and  H2  (Fig.  7,  C  and D).  The anti-H2 
COOH terminus antibodies (A and C) labeled cells coinci- 
dently with the ER-specific antibody (B), and this labeling 
pattern  was  easily  distinguished  from  that  of the  Golgi- 
specifc label (D). Because of superposition of  Golgi labeling 
with part of the ER, we cannot exclude that some of the H2 
labeling coincides with the Golgi complex, though most of 
it does not. Some cells that showed a stronger signal for H2, 
suggesting a higher level of H2 expression or a lower rate of 
degradation, gave an identical pattern of ER staining (Fig. 
7 A, cell at bottom)  as compared with the majority of the 
cells (Fig. 7 A, two cells at top). If H2 travels before degrada- 
tion from the RER to a new compartment, (a) this compart- 
ment must be part of or physically adjacent to the ER and 
therefore not distinguished by immunofluorescence or (b) 
degradation upon reaching the new compartment must be so 
rapid that we cannot detect H2 in it. 
Low Temperature Does Not Change the SubceUular 
Localization of H2 
Incubation of cells at 18-20°C drastically reduced the rate 
of degradation of H2 (Fig. 6). When 2-18 cells were incu- 
bated at 18°C for 5 h, we saw no change in the immunofluo- 
rescence pattern of H2 distribution, but a stronger signal was 
detected in all cells (Fig. 8 A as compared with Fig. 7 A). 
This indicates that H2 degradation is inhibited less than H2 
biosynthesis. All H2 is still in a compartment that stains with 
the anti-ER antiserum. It is unlikely that the reduced tem- 
perature would account for such a reduction in the degrada- 
tion rate if  the H2 were degraded within the RER. We believe 
that H2 is transported for degradation to an RER-adjacent, 
pre-Golgi compartment such as the transitional element of 
the ER and that such transport is inhibited at 18-20°C. 
Discussion 
Here we  show  that the  ASGP receptor subunit H2a,  ex- 
pressed in fibroblasts without HI, is degraded within 2-3 h 
of synthesis in a compartment that may be the ER itself or 
near the ER. Lysosomotropic agents do not affect the rate of 
degradation and do not cause accumulation of intermediates 
detectable with our antisera. Thus, we believe that degrada- 
tion occurs in a pre-Golgi, nonlysosomal compartment but 
cannot exclude final lysosome degradation of intermediates 
that are not reactive with our two anti-peptide sera. 
We have identified a  35-kD polypeptide that may result 
from the initial cleavage event in the degradation of H2. Evi- 
dence that the 35-kD protein is a fragment of H2 includes 
(a) it is not found in fibroblasts transfected with vector alone; 
(b) it has the same number of oligosaccharides as H2; (c) it 
reacts with the anti-H2 antibody specific for the COOH ter- 
minus, the part of H2 containing the sites for oligosaccharide 
addition; and (d) it is detected roughly during the period of 
time in which H2 is degraded. If we assume that the 35-kD 
protein results from a single endoproteolytic cleavage, then 
this site would be just COOH-terminal to the membrane- 
spanning region. Cell fractionation results (not shown) indi- 
cate that the 35-kD fragment is not tightly bound to the mem- 
brane,  consistent with  it being the exoplasmic,  nonmem- 
brane-spanning domain of H2. Our results indicate that the 
35-kD H2 fragment is formed before H2 reaches the medial 
Golgi compartment, as the 35-kD H2 fragment bears endo 
H-sensitive, endo D-resistant oligosaccharides. We do not 
know whether this cleavage is an obligatory initial step in the 
degradation pathway or if it is one of several initial cleavages 
that can take place. 
The membrane-spanning domain of the homologous pro- 
tein H1 functions as an internal uncleaved signal-anchor se- 
quence (Spiess and Lodish, 1986); we assume that the H2 
membrane-spanning sequence plays the same role. The posi- 
tion of the cleavage we observe-just COOH-terminal to this 
internal signal-anchor sequence-suggests that signal pepti- 
dase may be the culpable enzyme. Interestingly, when deriv- 
atives of HI eDNA that direct synthesis of a variant H1 pro- 
tein that lacks the NH2-terminal (cytoplasmic) domain were 
translated in vitro in the presence of microsomes, a fraction 
of  the protein made was proteolytically cleaved at the luminal 
side of the membrane-spanning region, suggesting that sig- 
nal peptidase recognized the internal signal sequence (Spiess 
and Lodish, 1986). This cleavage was not detected in normal 
H1, suggesting that the conformation of the protein as well 
as the presence of the signal-anchor sequence determines 
The Journal of Cell Biology,  Volume 109, 1989  3320 Figure 7. Double label immunolocalization of  H2 and the ER or Golgi complex. Fixed, permeabilized 2-18  cells were processed as described 
in Materials and Methods. A and B represent double labeling with anti-H2 and anti-ER antibodies; C and D represent double labeling 
with anti-H2 and anti-Golgi antibodies. H2 was detected with TRITC filter (.4 and C), and ER (B) or Golgi complex (D) were detected 
with FITC filter. Identical regions are labeled by arrows in the double label pairs, pointing out similarities in staining (A and B) or differences 
(C and D). Bar, 10/~m. 
whether signal peptidase acts, As H2 does not fold into an 
H1-H2 heterooligomer when synthesized in the absence of 
HI,  we  speculate  that  signal  peptidase  could recognize a 
cryptic cleavage site in  unfolded H2.  Candidate cleavage 
sites predicted by the method of yon Heijne (1986) are pres- 
ent in the area of the proteolytic clip. If cleavage by signal 
peptidase were an obligatory initial step in H2 degradation, 
however, we would expect that upon incubation at 18-20°C, 
Amara et al.  Unassembled ASGP Receptor Subunit Degradation  3321 Figure 8. Effect of 18-20°C on immunolocalization of H2, the ER, and the Golgi complex. 2-18 cells were incubated at 18-20°C for 5 h 
before fixation, permeabilization, and immunofluorescence  as in Fig. 7. (A and C) Anti-H2-TRITC; (B) anti-RER-FITC; (D) anti-Golgi- 
TRITC. Bar, 10 #m. 
which causes H2 to accumulate in the ER, all the H2 would 
become cleaved; instead, we find that intact H2 is much more 
stable than at 37°C.  Alternatively, the area of the cleavage 
may form a particularly protease-sensitive stalk between the 
membrane-spanning and more globular exoplasmic domains 
and be cleaved by a protease that is not found in the RER but 
rather in the degradative compartment. 
The proteolytic cleavage we observe with H2 is similar to 
the processing that occurs with many viral glycoproteins. 
Cells infected with viruses such as murine leukemia virus, 
The Journal of Cell Biology, Volume  109, 1989  3322 rabies,  and mouse  mammary  tumor virus  release  soluble 
forms  of  viral  glycoproteins  into  the  extracellular  fluid 
(Bolognesi et al.,  1975; Dietzschold et al.,  1983;  Racevskis 
and Sarkar,  1978).  The origin of the truncated glycoprotein 
has been well characterized  for vesicular  stomatitis virus, 
which directs the synthesis of a membrane bound glycopro- 
tein (G protein) in the RER. A truncated,  soluble form of G 
protein, Gs, lacks the membrane-spanning and cytoplasmic 
portions  of the  protein.  G~  is  formed  intracellularly  and 
released  by  infected  cells  (Garreis-Wabnitz  and  Kruppa, 
1984).  Use  of the  temperature-sensitive  ts045  mutant  of 
vesicular stomatitis virus G protein, which fails to fold into 
a trimer and leave the ER (Knipe et al.,  1977a,b;  Bergman 
et al.,  1981; Kreis and Lodish,  1986),  was instrumental  in 
proving that Gs is generated in the ER by cleavage of G pro- 
tein  at  a  site  near  the  luminal  surface of the  membrane- 
spanning domain (Chen and Huang,  1986).  Perhaps  this is 
another example of a virus exploiting a normal cellular func- 
tion, in this case quality  control for multisubunit protein as- 
sembly,  for its own purposes. 
The characteristics of H2 degradation  are essentially the 
same  as  those  described  by  Lippincott-Schwartz  and  co- 
workers (1988) for the t~ and/3 subunits of the T cell receptor, 
which are also degraded in a pre-Golgi compartment in 3T3 
fibroblasts.  The ASGP receptor bears no striking sequence 
homology with the T cell receptor subunits and yet it is a sub- 
strate for a similar pre-Golgi degradation  pathway. Since not 
all of the T cell receptor subunits  have yet been coexpressed 
in fibroblasts,  we do not know if 3T3 cells are capable of as- 
sembling the subunits  and transporting  them to the surface. 
2B4 T cell hybridoma cells, which express all seven subunits 
of the T cell receptor complex, degrade the unassembled a 
and B subunits  in the lysosomes (Lippincott-Schwartz et al., 
1988).  That leaves open the possibility that the fibroblasts 
are incapable of synthesizing the u and/~ subunits into a nor- 
mal conformation, and the grossly abnormal conformation 
triggers  the use of the pre-Golgi pathway. In contrast,  we 
know that 3T3 cells are capable of making a functional ASGP 
receptor and yet degrade a portion of both H1 and H2 in the 
process (Shia and Lodish,  1989).  We therefore suspect that 
the degradation process we describe here is the same as that 
occurring during cosynthesis of the two subunits  in fibre- 
blasts. It remains to be tested whether ER degradation  is the 
mechanism operating in hepatocytes to allow only properly 
assembled  H1-H2  complexes  to  mature.  In  addition,  we 
would like to find out whether H2 is completely degraded in 
2-18 cells because it cannot self-associate as compared with 
H1  which forms dimers and trimers in fibroblasts  that ex- 
press it alone (Shia and Lodish,  1989).  A  similar example 
would be vesicular stomatitis virus ts045 G protein, which 
cannot trimerize and becomes stuck in the ER (Kreis and 
Lodish, 1986). The generation and expression of mutant H2 
proteins may help us resolve this question. 
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